StockWatch
·
Specialty Chemicals
Board Meeting15 Jul 2026, 03:48 pm

Himadri Speciality Chemical Approves Capex for New Projects

AI Summary

Himadri Speciality Chemical Ltd announced board approval for significant capital expenditures across multiple projects. The company will invest ₹128 Crores to expand Anthraquinone and Carbazole manufacturing capacity, ₹70 Crores for India's first Carbon Nano Tubes (CNT) facility, and ₹170 Crores for Super Speciality Carbon Black production. These expansions aim to enhance production of high-value specialty products and reduce import dependency, aligning with the 'Atmanirbhar Bharat' vision. The board also approved the unaudited financial results for the quarter ended 30 June 2026.

Key Highlights

  • Board approved capex for Anthraquinone and Carbazole expansion.
  • New capex for India's first Carbon Nano Tubes (CNT) facility approved.
  • Investment in Super Speciality Carbon Black manufacturing capacity.
  • Expansions focus on high-value specialty products.
  • Unaudited financial results for Q1 FY27 declared.